Reposting on day that it was announced neoadjuvant only chemo-nivolumab delivers a long term survival benefit in surgically resectable lung cancer, 3 doses of therapy (compared to potentially 16+ in other perioperative/adjuvant immunotherapy regimens) #lcsm

🫁 M.Provencio on stage to challenge the unresectability concept. 🩻 The NADIM trial enrolled pathologically confirmed N2 and multiple N2 NSCLC. ✂️ The survival outcomes underscores that neoadjuvant chemotherapy + immunotherapy is the best ally of the surgeon to achieve a

Discover the latest MMCTS tutorial: Right robotic-assisted thoracic surgery retrograde fissureless en bloc S2/6 bisegmentectomy 📊 Skill level: Innovative Watch as a complex lung surgery is performed using the Da Vinci X system to resect a non-palpable lesion, followed by

What is the prognostic value of serum soluble mesothelin-related peptide (SMRP) and PD-L1 levels in malignant pleural mesothelioma patients receiving immune checkpoint therapy? Researchers say SMRP is a promising serum biomarker. Read in #JTCVS: doi.org/10.1016/j.jtcv…

NBA should take notes from the EuroLeague on how to start off the playoff series 😤🔥

This week in JANS, researchers examineed extended sleeve lobectomy after neoadjuvant immunochemotherapy for centrally located non-small cell lung cancer. Don't forget to contact CTSNet to subscribe to the JANS newsletter! 🔗ow.ly/Svhh50VLrSE #JANS #newsletter #weekly

Less than 3 weeks to go! ISMICSofficial 2025 in Istanbul is ready! Dont miss out on the wonderful program our cardiac and thoracic co-chairs have been working hard on all year! Registration still open Join us!! TSRA TSMA The Society of Thoracic Surgeons Mayo Clinic Cardiac Surgery Gulf Society for Cardiac Surgery

Ready to publish your study on thymic and pleural malignancies? #ITSOS2025 is the best place to submit. Present your abstract this September. All accepted submissions receive accelerated review by #JTCVS. Deadline is June 23, so share your research today: events.aats.org/international-…

Drew Moghanaki It’s a legitimate and important discussion. Particularly in the era of immunotherapy, the ideal extent of lymph node dissection is unknown. However, we have RCTs (z0030 for example) showing that complete lymph node dissection is safe and does NOT significantly increase morbidity

Editor's Choice: A propensity score–matched analysis of robotic and laparoscopic Ivor Lewis esophagectomy. Surgeons in Berlin, Germany, found that the textbook outcome is associated with improved survival. Read this study free until 6/30 in #JTCVS: doi.org/10.1016/j.jtcv…

.Jones David R., Chief of Thoracic Surgery at MSK, shared remarks during his presidential address at the 2025 AATS Annual Meeting. Dr. Jones touched on the history of the AATS, the organization’s emphasis on scholarships in the field, the importance of clinical trials, and

Lung cancer screening is ROLLING, ROLLING, ROLLING in West Virginia! #lcsm preventcancer.org/article/lung-c…

What are the outcomes and long-term prognosis of esophageal diversion at Pitt Cardiothoracic Surgery Department? Researchers say esophageal diversion ensures safe control of the crisis. Find out more by reading for free in #JTCVS: doi.org/10.1016/j.jtcv… Yota Suzuki

Another neoadjuvant/perioperative immunotherapy overall survival benefit! Lesson is if you are giving immunotherapy for earlier stage cancer it should be before surgery! #lcsm #ESMO25

Definitely wow!

It’s Lung Cancer Awareness Month! 🤍 Lung cancer remains the #1 cancer killer worldwide, but millions of patients, clinicians, and researchers are fighting back every day. Join them. Support the IASLC Foundation. Donate now: bit.ly/4nBZ6HU

Very pleased to see this work out in publication. SoC chemo IO cohorts from Montreal’ McGillThoracic and Centre de recherche du CHUM teams! Two of the top recruiting sites to CM816 and KN671 amongst other rNSCLC trials. Most novel finding: PET SUVmax reduction > 70% has AUC of 0.89 for PCR in a subset

Elon Musk on how Optimus will provide access to the best medical care for anyone in the world: “Imagine a world where everyone has access to the best surgeons, literally everyone. And Optimus will have the level of precision that is frankly superhuman and will be able to do

Best title ever for an editorial about lung cancer screening? Alexandra Potter Lecia Sequist, MD, MPH, FASCO Jeff Yang MD FACS

Lung cancer in nonsmoking individuals accounts for 15% to 20% of lung cancer cases worldwide. A review published in JAMA discusses the epidemiology, diagnosis, treatment, and prognosis of #LungCancer in nonsmoking individuals. ➡️ Watch the video for key takeaways and read the